AI-driven, 100% non-invasive, low-cost population screening tool that provides highly sensitive, confidence-scored, pre-symptomatic Alzheimer's risk assessments with multi-year risk stratification. Targets healthcare providers, insurers, governments and pharmaceutical companies for early detection, prevention, risk stratification and more efficient clinical trials.